Cambrex Corporation (CBM)’s Financial Results Comparing With Tenax Therapeutics Inc. (NASDAQ:TENX)

We will be contrasting the differences between Cambrex Corporation (NYSE:CBM) and Tenax Therapeutics Inc. (NASDAQ:TENX) as far as profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry.

Earnings and Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cambrex Corporation 579.01M 2.11 132.16M 3.87 11.50
Tenax Therapeutics Inc. N/A 0.00 5.93M -4.12 0.00

Table 1 shows the top-line revenue, earnings per share (EPS) and valuation for Cambrex Corporation and Tenax Therapeutics Inc.


Table 2 provides Cambrex Corporation and Tenax Therapeutics Inc.’s return on equity, net margins and return on assets.

Net Margins Return on Equity Return on Assets
Cambrex Corporation 22.83% 21.7% 14.5%
Tenax Therapeutics Inc. 0.00% -84.5% -77.3%

Risk and Volatility

A 2.4 beta indicates that Cambrex Corporation is 140.00% more volatile compared to S&P 500. Competitively, Tenax Therapeutics Inc. is 49.00% less volatile than S&P 500, because of the 0.51 beta.


The current Quick Ratio of Cambrex Corporation is 3.4 while its Current Ratio is 4.5. Meanwhile, Tenax Therapeutics Inc. has a Current Ratio of 10 while its Quick Ratio is 10. Tenax Therapeutics Inc. is better positioned to pay off its short-term and long-term debts than Cambrex Corporation.

Analyst Ratings

The Recommendations and Ratings for Cambrex Corporation and Tenax Therapeutics Inc. are featured in the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Cambrex Corporation 0 0 1 3.00
Tenax Therapeutics Inc. 0 0 0 0.00

$75.5 is Cambrex Corporation’s average target price while its potential upside is 107.08%.

Institutional & Insider Ownership

Institutional investors held 0% of Cambrex Corporation shares and 12.2% of Tenax Therapeutics Inc. shares. About 0.5% of Cambrex Corporation’s share are held by insiders. Comparatively, 2.4% are Tenax Therapeutics Inc.’s share held by insiders.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Cambrex Corporation -7.02% -21.26% -32.26% -2.69% -9.52% -7.35%
Tenax Therapeutics Inc. -38.43% -69% -73.4% -78.86% -81.87% -86.43%

For the past year Cambrex Corporation’s stock price has smaller decline than Tenax Therapeutics Inc.


On 10 of the 11 factors Cambrex Corporation beats Tenax Therapeutics Inc.

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. The companyÂ’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.